News Home
Explore

Pharmacy

Pharmacy

Premera Formulary: Biosimilar Value, HCLV Drug Guidance, and More

March 19, 2026
This month’s newsletter highlights biosimilars’ value, high-cost low-value drug guidance, and key formulary updates for prior authorization, step therapy, and limits.
Pharmacy

2026 Update: Prescription Drug Data Collection (RxDC) Reporting

February 19, 2026
A quick look at what you need to know for RxDC reporting—plus a critical April 24 deadline you can’t miss.

Read More

GLP-1s Still Making Headlines
Pharmacy

GLP-1s Still Making Headlines

February 19, 2026
With GLP 1s still dominating headlines and coverage evolving, this month’s update highlights what you need to know about rising demand and new market developments.

Read More

Pharmacy

Pharmacy Formulary and Medical Policy Changes for January 2026

December 19, 2025
Find out which drugs will require prior authorization and the preferred alternatives.

Read More

Pharmacy

White House Announces GLP-1 Drug Agreements

November 20, 2025
The White House announced new agreements with certain drugmakers to lower prices on some popular medications.

Read More

Banking on Affordability with Biosimilars
Pharmacy

Banking on Affordability with Biosimilars

November 20, 2025
Lowering the total cost of care for prescription drugs by making the switch to biosimilars.

Read More

Pharmacy

WA SB 5213 Pharmacy Benefit Mandate effective January 1, 2026

October 24, 2025
For fully insured groups in Washington state, your pharmacy model will change on January 1, 2026.

Read More

Show More